Table 3 Nulcear-Pin1 Staining and or Characteristics of MelanomaPatients.

From: Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis

Variables

Nulcear-Pin 1 Staining

Low, No. (%)

High, No. (%)

Total

Pa

Primary melanoma

Age, y

   ≤60

129 (72.9)

48 (27.1)

177

0.608

   >60

128 (75.3)

42 (24.7)

170

 

Sex

   Male

146 (74.9)

49 (25.1)

195

0.698

   Female

111 (73.0)

41 (27.0)

152

 

Tumor thickness, mm

≤1.0

87 (73.1)

32 (26.9)

119

0.008

   1.01–2.00

59 (63.4)

34 (36.6)

93

 

   2.01–4.00

47 (77.0)

14(23.0)

61

 

   >4.00

64 (86.5)

10 (13.5)

74

 

Ulceration

    Absent

206 (73.3)

75 (26.7)

281

0.509

   Present

51 (77.3)

15 (22.7)

66

 

Subtype

   Lentigomaligna

56 (76.7)

17 (23.3)

73

0.977

   Superficial spreading

95 (72.5)

36 (27.5)

131

 

   Nodular

39 (75.0)

13 (25.0)

52

 

   Acrolentigous melanoma

8 (72.7)

3 (27.3)

11

 

   Unspecified

59 (73.8)

21 (26.3)

80

 

Siteb

   Sun-protected

184 (73.4)

67 (25.7)

251

0.603

   Sun-exposed

73 (74.7)

23 (25.3)

96

 

Metastatic melanoma

Age, y

   ≤59

85 (85.0)

15 (15.0)

100

0.383

   >59

73 (80.2)

18 (19.8)

91

 

Sex

   Male

112 (83.6)

22 (16.4)

134

0.630

   Female

46 (80.7)

11 (19.3)

57

 

AJCC stage

   I

135 (68.9)

61 (31.1)

196

0.0001

   II

122 (80.8)

29 (19.2)

151

 

   III

73 (93.6)

5 (6.4)

78

 

   IV

85 (75.2)

28 (24.8)

113

 
  1. AJCC indicates American Joint Committee on Cancer.
  2. aChi - square test.
  3. bSun-protected sites: trunk, arm, leg, back, and feet; sun-exposed sites: head and neck.